Eli Lilly and Company (BIT:1LLY)
Italy flag Italy · Delayed Price · Currency is EUR
660.60
+1.80 (0.27%)
At close: Jul 3, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Glucagon
-
Log In
Log In
Log In
Log In
Upgrade
Glucagon Growth
-
Log In
Log In
Log In
Log In
Upgrade
Humalog
2.32B
Log In
Log In
Log In
Log In
Upgrade
Humalog Growth
33.44%
Log In
Log In
Log In
Log In
Upgrade
Humulin
917.10M
Log In
Log In
Log In
Log In
Upgrade
Humulin Growth
9.66%
Log In
Log In
Log In
Log In
Upgrade
Trajenta
353.90M
Log In
Log In
Log In
Log In
Upgrade
Trajenta Growth
-12.49%
Log In
Log In
Log In
Log In
Upgrade
Oncology
8.75B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
24.99%
Log In
Log In
Log In
Log In
Upgrade
Neuroscience
1.47B
Log In
Log In
Log In
Log In
Upgrade
Neuroscience Growth
-53.34%
Log In
Log In
Log In
Log In
Upgrade
Other Product
903.00M
Log In
Log In
Log In
Log In
Upgrade
Other Product Growth
-19.74%
Log In
Log In
Log In
Log In
Upgrade
Jardiance
3.34B
Log In
Log In
Log In
Log In
Upgrade
Jardiance Growth
28.56%
Log In
Log In
Log In
Log In
Upgrade
Trulicity
5.25B
Log In
Log In
Log In
Log In
Upgrade
Trulicity Growth
-26.00%
Log In
Log In
Log In
Log In
Upgrade
Basaglar
676.90M
Log In
Log In
Log In
Log In
Upgrade
Basaglar Growth
2.41%
Log In
Log In
Log In
Log In
Upgrade
Other Cardiometabolic Health
187.90M
Log In
Log In
Log In
Log In
Upgrade
Other Cardiometabolic Health Growth
-8.46%
Log In
Log In
Log In
Log In
Upgrade
Immunology
4.39B
Log In
Log In
Log In
Log In
Upgrade
Immunology Growth
20.58%
Log In
Log In
Log In
Log In
Upgrade
Other
100.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Baqsimi
29.10M
Log In
Log In
Log In
Log In
Upgrade
Baqsimi Growth
-
Log In
Log In
Log In
Log In
Upgrade
Mounjaro
11.54B
Log In
Log In
Log In
Log In
Upgrade
Mounjaro Growth
112.08%
Log In
Log In
Log In
Log In
Upgrade
Zepbound
4.93B
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
US Revenue
30.38B
Log In
Log In
Log In
Log In
Upgrade
US Revenue Growth
43.91%
Log In
Log In
Log In
Log In
Upgrade
Europe
6.92B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
20.60%
Log In
Log In
Log In
Log In
Upgrade
Japan
1.81B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
12.36%
Log In
Log In
Log In
Log In
Upgrade
Other Foreign Countries
4.27B
Log In
Log In
Log In
Log In
Upgrade
Other Foreign Countries Growth
38.21%
Log In
Log In
Log In
Log In
Upgrade
China
1.66B
Log In
Log In
Log In
Log In
Upgrade
China Growth
12.44%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Revenue Change due to Price
5.00
Log In
Log In
Log In
Log In
Upgrade
Revenue Change due to Price Growth
-
Log In
Log In
Log In
Log In
Upgrade
Revenue Change due to Volume
27.00
Log In
Log In
Log In
Log In
Upgrade
Revenue Change due to Volume Growth
64.37%
Log In
Log In
Log In
Log In
Upgrade
Revenue Change due to FX
-
Log In
Log In
Log In
Log In
Upgrade
Revenue Change due to FX Growth
-
Log In
Log In
Log In
Log In
Upgrade